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Cells to Surgery Quiz
QUESTIONS
1.  A 54-year-old white man presents with the lesion shown above on his left lower arm and a similar-appearing lesion on his 
left upper back. There is no regional lymphadenopathy, and he is otherwise asymptomatic. Histopathologic and immuno-
histochemical analyses of the lesion shown are consistent with a primary melanoma with a thickness of 2.40 mm. The 
lesion on the patient’s back reveals findings concerning for a possible metastatic melanoma to the skin with a thickness of 
3.20 mm. Which of the following is a tumor-produced extracellular matrix protein that could help distinguish a metastatic 
melanoma to the skin from a second primary melanoma and guide further workup for this patient?
 a. Capsase 3.
 b. Cyclin-dependent kinase 2 (CDK-2).
 c. Cyclin-dependent kinase 6 (CDK-6).
 d. Phospholipase A2.
 e. Transforming growth factor-β–inducible (TGFBI) protein.
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Image appears with permission from VisualDx.  © Logical Images, Inc.
JID and Logical Images, Inc., have cooperated to offer the Cells to Surgery Quiz, 
incorporating diagnostic images from VisualDx’s vast database. Questions relate to 
the image as well as to selected articles in JID, which are listed after the questions. 
Answers will be posted as supplementary material. We hope you enjoy this challenge.
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2.  A drug company is interested in developing an antibody against the protein that was used to 
distinguish metastatic melanoma to the skin from a second primary melanoma in the hope of 
controlling outgrowth of metastases. Which of the following phases of the cell cycle is most 
likely to be affected by this drug?
 a.  G1.
 b.  G1/S transition.
 c.  G2. 
 d. M phase.
 e. G0.
3.  The appropriate steps in management were undertaken. Four months later, the patient com-
plained of frequent headaches, and he was found to have metastases to the brain and left lung. 
The patient underwent cytotoxic treatment with a serine/threonine kinase BRAF inhibitor. Three 
months after treatment was started, the metastatic lesions in the brain and left lung have grown 
significantly. You suspect this may be due to a case of rapid repopulation of tumor cells that can 
occur after cytotoxic therapy. A drug that targets which of the following proteins might have 
helped to prevent this complication?
 a. Arachidonic acid.
 b. Caspase 3.
 c.  Cyclin-dependent kinase 2 (CDK-2).
 d. Cyclin-dependent kinase 6 (CDK-6).
 e.  Phospholipase A2.
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